Cargando…

Emerging and reemerging forms of Trypanosoma cruzi transmission

This review aims to update and discuss the main challenges in controlling emergent and reemergent forms of Trypanosoma cruzi transmission through organ transplantation, blood products and vertical transmission in endemic and non-endemic areas as well as emergent forms of transmission in endemic coun...

Descripción completa

Detalles Bibliográficos
Autor principal: Shikanai Yasuda, Maria Aparecida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113729/
https://www.ncbi.nlm.nih.gov/pubmed/35584508
http://dx.doi.org/10.1590/0074-02760210033
_version_ 1784709632982253568
author Shikanai Yasuda, Maria Aparecida
author_facet Shikanai Yasuda, Maria Aparecida
author_sort Shikanai Yasuda, Maria Aparecida
collection PubMed
description This review aims to update and discuss the main challenges in controlling emergent and reemergent forms of Trypanosoma cruzi transmission through organ transplantation, blood products and vertical transmission in endemic and non-endemic areas as well as emergent forms of transmission in endemic countries through contaminated food, currently representing the major cause of acute illness in several countries. As a neglected tropical disease potentially controllable with a major impact on morbimortality and socioeconomic aspects, Chagas disease (CD) was approved at the WHO global plan to interrupt four transmission routes by 2030 (vector/blood transfusion/organ transplant/congenital). Implementation of universal or target screening for CD are highly recommended in blood banks of non-endemic regions; in organ transplants donors in endemic/non-endemic areas as well as in women at risk from endemic areas (reproductive age women/pregnant women-respective babies). Moreover, main challenges for surveillance are the application of molecular methods for identification of infected babies, donor transmitted infection and of live parasites in the food. In addition, the systematic recording of acute/non-acute cases and transmission sources is crucial to establish databases for control and surveillance purposes. Remarkably, antiparasitic treatment of infected reproductive age women and infected babies is essential for the elimination of congenital CD by 2030.
format Online
Article
Text
id pubmed-9113729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-91137292022-05-31 Emerging and reemerging forms of Trypanosoma cruzi transmission Shikanai Yasuda, Maria Aparecida Mem Inst Oswaldo Cruz Review This review aims to update and discuss the main challenges in controlling emergent and reemergent forms of Trypanosoma cruzi transmission through organ transplantation, blood products and vertical transmission in endemic and non-endemic areas as well as emergent forms of transmission in endemic countries through contaminated food, currently representing the major cause of acute illness in several countries. As a neglected tropical disease potentially controllable with a major impact on morbimortality and socioeconomic aspects, Chagas disease (CD) was approved at the WHO global plan to interrupt four transmission routes by 2030 (vector/blood transfusion/organ transplant/congenital). Implementation of universal or target screening for CD are highly recommended in blood banks of non-endemic regions; in organ transplants donors in endemic/non-endemic areas as well as in women at risk from endemic areas (reproductive age women/pregnant women-respective babies). Moreover, main challenges for surveillance are the application of molecular methods for identification of infected babies, donor transmitted infection and of live parasites in the food. In addition, the systematic recording of acute/non-acute cases and transmission sources is crucial to establish databases for control and surveillance purposes. Remarkably, antiparasitic treatment of infected reproductive age women and infected babies is essential for the elimination of congenital CD by 2030. Instituto Oswaldo Cruz, Ministério da Saúde 2022-05-16 /pmc/articles/PMC9113729/ /pubmed/35584508 http://dx.doi.org/10.1590/0074-02760210033 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Review
Shikanai Yasuda, Maria Aparecida
Emerging and reemerging forms of Trypanosoma cruzi transmission
title Emerging and reemerging forms of Trypanosoma cruzi transmission
title_full Emerging and reemerging forms of Trypanosoma cruzi transmission
title_fullStr Emerging and reemerging forms of Trypanosoma cruzi transmission
title_full_unstemmed Emerging and reemerging forms of Trypanosoma cruzi transmission
title_short Emerging and reemerging forms of Trypanosoma cruzi transmission
title_sort emerging and reemerging forms of trypanosoma cruzi transmission
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113729/
https://www.ncbi.nlm.nih.gov/pubmed/35584508
http://dx.doi.org/10.1590/0074-02760210033
work_keys_str_mv AT shikanaiyasudamariaaparecida emergingandreemergingformsoftrypanosomacruzitransmission